CNTX (STOCKS)
Context Therapeutics Inc. Common Stock
$0.506400
+0.036500 (+7.77%)
Prev close: $0.469900
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Martin A. Lehr
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $46.55M
- Employees
- 9
- P/E (TTM)
- -0.96
- P/B (TTM)
- 1.13
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Operating Income/Loss | -$48.73M |
| Income/Loss From Continuing Operations After Tax | -$45.96M |
| Income/Loss From Continuing Operations Before Tax | -$45.96M |
| Net Income/Loss | -$45.96M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$45.96M |
| Net Income/Loss Available To Common Stockholders, Basic | -$45.96M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.48 |
| Diluted Earnings Per Share | -$0.48 |
| Basic Average Shares | 190,368,242 |
| Diluted Average Shares | 190,368,242 |
| Assets | $46.13M |
| Current Assets | $45.82M |
| Noncurrent Assets | $315.29K |
| Fixed Assets | $74.07K |
| Other Non-current Assets | $241.22K |
| Liabilities | $7.96M |
| Current Liabilities | $7.88M |
| Accounts Payable | $3.29M |
| Wages | $723.36K |
| Other Current Liabilities | $3.87M |
| Noncurrent Liabilities | $77.52K |
| Equity | $38.17M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $38.17M |
| Liabilities And Equity | $46.13M |
| Net Cash Flow From Operating Activities | -$33.97M |
| Net Cash Flow From Operating Activities, Continuing | -$33.97M |
| Net Cash Flow From Investing Activities | -$6.56M |
| Net Cash Flow From Investing Activities, Continuing | -$6.56M |
| Net Cash Flow From Financing Activities | $23.00M |
| Net Cash Flow From Financing Activities, Continuing | $23.00M |
| Net Cash Flow | -$17.52M |
| Net Cash Flow, Continuing | -$17.52M |
| Comprehensive Income/Loss | -$45.96M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$45.96M |
| Other Comprehensive Income/Loss | $0.00 |